Kiran Mazumdar-Shaw Quotes

Unfortunately, our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon as a bellwether stock. A stock that is differentiated, a stock that is focused on R&D, and a very, very strong balance sheet with huge value drivers at the end of it.
Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw

Quotes to Explore

Citatis.com uses cookies and complies with California Consumer Privacy Act.
By continuing to use the site you consent to our policies regarding cookies and personal data processing.